Tag: vaccine

  • Kiran Mazumdar Shaw: How Biocon Founder Became India’s First Biotech Queen?

    India is among the top 12 biotechnology destinations in the world, comprising around 600 biotech companies. In this article, you are going to find information about such a person who has made wealth all on his own, with sheer hard work and perseverance.

    Kiran Majumdar Shaw is an Indian Entrepreneur and Philanthropist who founded a biotechnology company, Biocon Limited in Bangalore, India. She is the Chairperson and Managing Director of Biocon. She received the Othmer Gold Medal for her exceptional contributions to the progress of science and chemistry. Financial Times named her in the business list of top 50 women. Forbes listed her as the 65th most powerful woman in the world. She was also named EY World Entrepreneur Of The Year 2020. She was ranked #2 in the Women Philanthropist list of 2019 by the Hurun Report India Philanthropy List 2019. As of the year 2020, she has an estimated net worth of $4.6 billion.

    Kiran Mazumdar is the executive chairperson and the founder of one of the most prominent biopharmaceutical companies around the globe, Biocon Limited. Kiran is a person who is an inspiration to thousands of women out there who are aspiring to become entrepreneurs. Read Kiran Mazumdar Shaw’s Success Story and know more about the journey of this amazing and inspiring woman.

    Kiran Mazumdar Shaw – Biography

    Name Kiran Mazumdar-Shaw
    Year of Birth 23 March 1953
    Nationality Indian
    Education Graduate degree in brewing from the University of Ballarat, Melbourne
    Profession Entrepreneur, Brewmaster
    Title Executive Chairperson – Biocon Limited and Biocon Biologics Limited
    Net Worth 370 crores USD
    Spouse John Shaw

    Kiran Mazumdar Shaw – Personal Life
    Kiran Mazumdar Shaw – Education
    Kiran Mazumdar Shaw – Professional Life & Career
    Kiran Mazumdar Shaw – Founder of Biocon
    Kiran Mazumdar Shaw – Expansion of Biocon
    Kiran Mazumdar Shaw – Board Memberships
    Kiran Mazumdar Shaw – Challenges Faced in Entrepreneurship
    Kiran Mazumdar Shaw – Success story
    Kiran Mazumdar Shaw – Philanthropy
    Kiran Mazumdar Shaw – Awards & Recognitions

    Kiran Mazumdar Shaw Success Story

    Kiran Mazumdar Shaw – Personal Life

    Kiran Mazumdar-Shaw and John Shaw
    Kiran Mazumdar-Shaw and John Shaw

    Kiran Mazumdar-Shaw was born to Gujarati parents in Banglore on 23rd March 1953, in a middle-class family. Her father, Rasendra Mazumdar was the head brewmaster at United Breweries.

    Since childhood, she aspired to become a doctor but couldn’t get a scholarship. In 1974, she was the only girl pursuing brewery course and topped in her class. At the age of 44, Kiran got married to John Shaw in the year 1989. John was working as the chairman at Madura Coats but left the job to join Biocon with Kiran. John Shaw is serving as the Vice Chairman of Biocon since 2001.

    Kiran Mazumdar Shaw – Education

    Kiran initially wanted to follow in her father’s footsteps. She studied at Bangalore’s Bishop Cotton Girl’s high school.

    She then took a pre-university course from an affiliate of Bangalore University, Mount Carmel College. She further graduated with a bachelor’s degree in zoology from Bangalore University in 1973.

    Kiran wanted to pursue medical college but was unable to get any scholarship in any medical college. Her father then suggested to pursue fermentation science and get trained as a brewmaster, which is a very non-traditional field for women. She went to Ballarat College, Melbourne University in Australia to study malting and brewing. She earned her degree of master brewer in 1975. Kiran Shaw was the only woman who opted for the brewing course and with her intelligence, she topped in her class.

    Kiran Mazumdar Shaw – Professional Life & Career

    Kiran Mazumdar-Shaw with Leslie Auchincloss
    Kiran Mazumdar-Shaw with Leslie Auchincloss

    Kiran started her professional career from Carlton and United Breweries, Melbourne, where she worked as a trainee brewer. Kiran Mazumdar completed her training in Carlton and United Breweries. She also worked at Barrett Brothers and Burston, Australia, as a trainee maltster.

    After coming back to India, she joined Jupiter Breweries in Calcutta as a technical consultant, and after gaining some experience there she worked as a Technical Manager at Standard Maltings Corporation situated in Baroda. She opted to further her career in Bangalore or Delhi but was told that “it’s a man’s profession” and that woman would not be employed as a master brewer in India.

    She started looking for work overseas and was given a position in Scotland. Leslie Auchincloss, the founder of Biocon Biochemicals Limited, of Cork, Ireland met Mazumdar before she could relocate. His firm produced enzymes used in the brewing, food packaging, and textile sectors.

    He was searching for an Indian entrepreneur to assist in the formation of a subsidiary in India. Kiran worked with the firm, and this was a life-changing opportunity for her. Leslie prepared her to work as a manager at his firm. Kiran went to India and began working for Biocon in a leased garage in Bangalore with an initial investment of 10,000 INR after she had a better understanding of the company’s operations and sales.

    Kiran Mazumdar Shaw – Founder of Biocon

    Kiran Mazumdar Shaw Founded Biocon Logo
    Kiran Mazumdar Shaw Founded Biocon Logo

    Kiran started with Biocon in 1978, she faced many challenges because of her youth, gender, and her untested business model. No bank wanted to lend her money, thus funding was a big issue.

    After getting her first funding she started with her first factory which was in a nearby 3000 sq. ft shed. The extraction of papain (a papaya enzyme used to tenderize the meat) and isinglass were the company’s first efforts (obtained from tropical catfish and used to clarify beer).

    Biocon India was the first Indian firm to make enzymes and ship them to the United States and Europe within a year of its founding. Kiran invested her first year’s profits in a 20-acre property, with plans to grow in the future. Kiran transformed Biocon India from an enzyme manufacturing firm to a fully integrated biopharmaceutical company because of her unique thinking and ideas.

    In 1984 Kiran discovered some new dimensions. At Biocon, a research and development team was created to focus on the development of innovative solid substrate fermentation methods. Biocon Pharmaceuticals was the first Indian biotech business to obtain funding from the United States for unique technology.

    Kiran started looking for alternative opportunities which were cost-effective as well low-cost. She had also proposed that drug companies be cost-sensitive in marketing to developing countries so that people can afford the drugs they need.

    Kiran and her husband John have always seen the need to provide people with the best they can, thus increasing and supplying affordable vaccines and medicines in India and helping society to overcome their medical requirements.

    Kiran Mazumdar Shaw – Expansion of Biocon

    Biocon Subsidiaries
    Biocon Subsidiaries

    She managed to establish two subsidiaries of Biocon including, Syngene in 1994 and Clinigene in 2000. Syngene provided a contractual basis early research and development support service while Clinigene focused on clinical research trials and the development of both generic and new medicines. Clinigene was later merged in Syngene and it has a current market cap of Rs.14,270.

    She incorporated Biocon Biopharmaceuticals Private Limited (BBLP) in 1990 to manufacture and market a select range of biotherapeutics in a joint venture with the Cuban Center of Molecular Immunology.


    Upasana Taku – Mobikwik Co- Founder | Biography | Education
    Upasana Taku, Mobikwik Co-Founder, is the first Indian woman leader in fintech. Read the biography of Upasana Taku and know her success mantra.


    Kiran Mazumdar Shaw – Board Memberships

    She is a member of the board of governors of the Indian School of Business and a term member of on the board of MIT, USA till 2023. She has been a former member of the Indian Institute of Technology Hyderabad. She was the first woman to head the board of governors of the Indian Institute of Management Bangalore (IIMB).

    She is an independent director on the board of Infosys. She is a member of the General Body of Maharashtra State Innovation Society. She is also a member of the advisory board of the MIT Jameel Clinic.

    Kiran Mazumdar Shaw – Challenges Faced in Entrepreneurship

    She started with a seed capital of Rs.10,000. Inspite of being a joint venture, Indian laws restricted foreign ownership to only 30% of the company. Thus, 70% of the company belonged to Kiran Mazumdar Shaw.

    She faced reliability challenges because of her youth, gender, and untested business model. She was unable to secure funding for her company initially. She tried hard and finally got her first financial backing. She also struggled while recruiting people to work for her startup. She had to face technological changes with an eye to building a biotech business in India, which was then having a poor infrastructure.


    Top 35 Successful Women Entrepreneurs In India [2022 Updated List]
    Women entrepreneurship is growing at a fast pace in Idnia. so we have listed some of the most successful women entrepreneurs in India.


    Kiran Mazumdar Shaw – Success story

    Kiran met Leslie Auchincloss, who is the founder of Biocon Biochemicals Limited, of Cork, Ireland. The aforesaid company produces enzymes to be used in brewing, food packaging, and textile industries. Auchincloss was desperately looking for an entrepreneur in India, who would help her in establishing an Indian subsidiary of Biocon.

    Kiran agreed to undertake the offer on a condition that if she did not wish to continue post six months, she would be given the position of brewmaster. She started working as a trainee manager at Biocon Limited, Cork, Ireland to learn more of the business. Post the training period, she returned India to establish the business.

    In 1989, Biocon Biochemicals of Ireland was acquired from Leslie Auchincloss by Hindustan Unilever. The partnership with Unilever helped Biocon to establish best practices and quality systems across the world. Unilever then sold its chemical division including Biocon to Imperial Chemical Industries (ICI). Her husband, John Shaw invested $2 million to purchase the shares of Biocon from ICI.

    Kiran Mazumdar Shaw – Philanthropy

    Kiran Mazumdar-Shaw The Giving Pledge
    Kiran Mazumdar-Shaw The Giving Pledge

    With the great success of her company, Biocon has allowed Kiran to donate and be the support of the people who need help but do not have the resources. Kiran is a firm believer in sharing and cares about people hence giving at least half of her wealth to philanthropic work. This was when she joined The Giving Pledge movement in the year 2015.  

    With the support of her husband John, she started up with Mazumdar Shaw Foundation in India to help the needful. The key sectors of the foundation are Education, Healthcare, Art & Culture, and a Healthy Environment. The Foundation is involved in numerous health and education outreach programs to benefit the economically weaker sections of Indian society.

    Mazumdar Shaw Medical Center
    Mazumdar Shaw Medical Center

    Mazumdar Shaw foundation has also established a 1400 bed cancer care center in Bangalore, in collaboration with Devi Shetty. Her goal is to create a world-class cancer center with affordable treatment.

    Kiran Mazumdar Shaw – Awards & Recognitions

    Kiran Mazumdar honoured by the Government of India
    Kiran Mazumdar honoured by the Government of India

    Kiran Mazumdar has been awarded several times for her leadership and  success in entrepreneurship.

    • She has been Conferred with the Bombay Management Association (BMA) Business Leader of The Decade Award in 2022.
    • She has been awarded with the “Spirit of TiE – Trailblazers Award” by TiE Bangalore on World Entrepreneurs Day in 2021.
    • Biocon has been recognized among the Top 20 in the The Medicine Maker Power List 2019 under the Business Captains category in 2019.
    • Kiran has received Padma Shri in the year 1989 and Padma Bhushan in the year 2005.
    • Recipient of EY World Entrepreneur of the Year (2020) and EY Entrepreneur of the Year India Award (2019).
    • Recipient of Order of Australia (2020).
    • Recipient of ICMR’s Lifetime Achievement Award for Outstanding Achievement in Healthcare (2019).
    • Recipient of AWSM Award for Excellence (2017).
    • Knight of the National Order of the French Legion of Honour (2016).
    • Recipient of Othmer Gold Medal (2014).
    • Recipient of Global Economy Prize for Business (2014).
    • Ranked among the world’s 16 Most Powerful Women in Leadership in 2021 by CEO Magazine.

    Kiran is also fond of writing books and she loves reading novels. She has written and has got published two books: ‘Ale and Arty’ and ‘India’s Innovation Challenge for Inclusive Development.

    Conclusion

    The second richest self-made woman in India is the star and pride of the nation. Nobody knew about Kiran Mazumdar-Shaw but now she is one of the most influential women in the country. She has shown the world that a woman can do everything and is a living inspiration for young woman entrepreneurs.

    FAQs

    Who is the husband of Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw is married to John Shaw.

    How old is Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw was born on 23 March 1953 and is 69 years old (2022).

    What is the net worth of Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw has a net worth of  $370 crores as of 2022.

    What is Kiran Mazumdar-Shaw’s education?

    Kiran Mazumdar-Shaw has done bachelor’s degree in zoology from Bangalore University in 1973 and earned a degree as master brewer in 1975 from Melbourne University in Australia.

  • List of Indian Companies that are providing Covid vaccine to its Employees

    The Covid cases in India has seen a surge due to the second wave in the country. Amidst the rise in cases and the shortage of vaccines certain Indian companies have announced that they would provide vaccination for their employees.

    A handful of companies have also announced that they would provide the vaccination to the families of their employees as well as the third parties involved with the company’s day to day activities. Let’s look at the different companies who have announced that they would provide vaccines to the employees.

    Wipro
    Sony India
    Indian Bank Association
    Hindustan Uniliver
    ITC
    TCS and Infosys
    Reliance Industries
    All India Petroleum Dealers Association (AIPDA)
    Indigo
    Capgemini
    upGrad
    Betterplace
    Atos
    ICICI Bank
    HDFC Bank
    Piramal Enterprises Limited
    FAQ

    Wipro

    Wipro had announced that it would start its Covid vaccination drive for its employees in their Electronic city campus in Bangalore. A spokesperson of Wipro had conveyed that the company is taking all the measures in order to start vaccination camps in all their other branches in the country.

    Sony India

    Sony India had provided a policy for its employees which is a Mediclaim policy in order to cover the expenses for the Covid treatment of their employees at home. The company has announced that it is in the process of setting up vaccination camps for their employees.

    Indian Bank Association

    The Indian Bank Association had made an announcement conveying that the vaccination of the Bank employees should be given the top most priority. They added that around 10 lakh bank employees should be vaccinated immediately and the expenses should be reimbursed. But the association had left the decision towards the individual banks in regards to the vaccination.

    Hindustan Uniliver

    A HUL spokesperson had conveyed that the company is looking forward to vaccinate all its employees as government has given permission to provide vaccination for the individuals above the age of 18. However, the shortage in the availability of vaccines have been a setback.


    Why Restaurant bodies are seeking waiver – The Performance of Restaurant Industry from 2020 to 2021
    The major cities of India are under a lockdown with the Covid cases rising allover the country. The second wave of the virus was an unexpected hit towards thecountry causing a lot of casualties among the citizens and a lot of businessesgoing down. With regards to it, the National Restaurant Assoc…


    ITC

    Amitav Mukherji who is the HR head of ITC have conveyed that the managers have been designated by the company to conduct the vaccination drives across various locations in the country by tying up with healthcare facilities. ITC has also announced that they would provide the vaccination drive towards their service providers as well as their supply chain partners.

    TCS and Infosys

    TCS have announced that they are working on various types of models in order to conduct vaccination drives with direct partnership with their suppliers. In the same way the HR head of Infosys has conveyed that they are in discussions with the healthcare providers and vaccine suppliers.

    Reliance Industries

    Nita Ambani who is a non-executive director of Reliance Industries had conveyed in a letter to their employees that the company will provide vaccination for them as well as their family members. It is estimated that the company has a count of 2,00,000 people.

    All India Petroleum Dealers Association (AIPDA)

    Ajay Bansal who is the President of the association has conveyed that the vaccination of all the petrol pump attendants and staffs should be given the top most priority and that they should be considered as essential workers.

    He has conveyed that the Government should ask the oil marketing companies or find some other mechanism to vaccinate them as they were considered as an essential worker during the lockdown and were not considered eligible to receive the vaccination jabs.


    How to manage stress during the Second wave of pandemic
    As we entered the new decade, the pandemic took a major turn. Being stuck at ourhome with the deadly virus outside has made lives really tough for people. Itresulted in anxious behaviour and massive depression symptoms. People are suffering from a huge breakdown during the pandemic. The second w…


    Share of People who received at least one does of vaccine
    Share of People who received at least one does of vaccine

    Indigo

    Indigo has also announced that they would vaccinate their employees and their family members. The company has announced that they are working towards providing vaccinations in a phased manner so that their operations doesn’t get affected.

    Capgemini

    Capgemini had also announced that they would provide vaccinations to all their employees and also their dependents. The company has also tied up with wellness consultants in order to resolve the doubts and queries related to vaccination.

    upGrad

    upGrad had also announced that they would provide vaccination for its employees as well as their family members. The ed-tech company has announced that they would provide vaccines to full-time employees, interns, contract-based employees as well as their ex-employees.

    Betterplace

    Betterplace which is a tech-based company has announced that they would cover the full cost of the vaccination cost of their employees and their dependants. The company is also providing a day off for their employees on the day of their vaccination.


    List of all the Companies helping India fight COVID-19 Wave
    The increase in the Covid-19 cases has led to a lot of tech companies and bigcorporates helping India during the crisis. The second wave of the coronaviruspandemic has hit India really hard with the daily cases rising and the deaths inthe country increasing. The citizens of the country are findi…


    Atos

    Atos which is an IT and a consulting firm has announced that it would cover the cost of the vaccination for its employees as well as their dependents under the medical insurance programme of the company. The company also conveyed that they would work together with local healthcare providers of the companies to implement the vaccination programme.

    ICICI Bank

    ICICI Bank has also announced that they would provide vaccination for their employees and their immediate family members. The bank has conveyed that it was a gesture of appreciation from the company towards its employees for dedicating their service during the tough times.

    HDFC Bank

    HDFC Bank has also announced that they would provide vaccinations for over 1 lakh employees and their family members. The bank has announced that they would reimburse the expenses for the mandated two doses of the vaccines.

    Piramal Enterprises Limited

    The company has announced that they would provide vaccines for their employees and their immediate family members and the choice of getting vaccinated is optional for their employees. They have set up a help desk across their offices for answering the queries of the employees.

    FAQ

    When did Covid vaccinations start in India?

    16 march, 2021

    How many Covid vaccines are produced daily in India?

    This means, on a daily basis, 28.33 lakh doses of the COVID-19 vaccine are produced in the country.

    Are Indian companies providing covid vaccine to its employees?

    Yes, Many major companies in India are providing Covid vaccination for free to its employees.

    Conclusion

    However, these are the major companies that have announced to provide vaccinations to their employees. Almost all the companies have decided to provide free vaccination to all their employees, in which around 70% of the companies are offering it to the dependents of their employees as well.

  • Pfizer – One of the Leading Biopharmaceutical Companies In the World

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Pfizer.

    Health and Human Services Secretary Alex Azar said that the US was currently manufacturing doses for all six potential vaccines backed by President Donald Trump’s government across more than 23 manufacturing facilities. These includes vaccines from Moderna, Pfizer, AstraZeneca and Johnson & Johnson, which are all in late-stage testing.

    Pfizer is a research-based multinational biopharmaceutical corporation that develops, manufactures, and distributes healthcare products. Medicines and vaccines are part of its global portfolio. The Pfizer–BioNTech COVID-19 vaccine is an mRNA-based COVID-19 vaccine that is marketed under the brand name Comirnaty. It is given to people aged 16 and up to protect them from infection with the SARS-CoV-2 virus, which causes COVID-19.

    This article will give you a complete Company Profile of Pfizer. Know all about Pfizer history, business model, founders, revenue, acquisition, covid-19 vaccine & more…

    Pfizer – Company Highlights

    Company Name Pfizer Inc.
    Headquarters New York City, New York
    Industry Pharmaceutical
    Founders Charles Pfizer and Charles F. Erhart
    Founded 1849
    Products Pharmaceuticals, vaccines
    Current CEO Albert Bourla
    Areas Served Worldwide
    Website pfizer.in

    Pfizer – Latest News
    About Pfizer and How it Works?
    Pfizer – Mission and Vision
    Pfizer – Founder and History
    Pfizer – Covid-19 Vaccine
    Pfizer – Key Pharmaceutical Products
    Pfizer – Name, Logo, and Tagline
    Pfizer – Business Model
    Pfizer – Key Financial Metrics
    Pfizer – Revenue and Growth
    Pfizer – Investments
    Pfizer – Acquisitions
    Pfizer – Competitors
    Pfizer – Challenges Faced
    Pfizer – Future Plans
    Pfizer – FAQs

    Pfizer – Latest News

    Pfizer/BioNTech has filed an application with the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people aged 16 and up as of May 2021, according to the companies. This is the first Covid-19 vaccine to be evaluated by the FDA for complete approval in the United States.

    The FDA has granted emergency use authorization (EUA) to Pfizer’s mRNA two-shot vaccine for use in the United States. To date, 170 million doses of the vaccine have been distributed throughout the United States, according to the firms.

    “We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. Government,” Albert Bourla CEO of Pfizer, said in a statement.

    “We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”


    Apps & Websites to get alert of Covid Vaccines Slot
    The second wave of the Covid-19 cases has been increasing in the country for thepast few months. The daily active cases are rising and currently, India hasseen the greatest number of single-day cases around the world. The country has atotal of around 2.15 crore active cases and 2.34 lakh deaths …


    About Pfizer and How it Works?

    Pfizer is a research-based multinational biopharmaceutical corporation that develops, manufactures, and distributes healthcare products. Medicines and vaccines are part of its global portfolio.

    Cholesterol-lowering Lipitor, pain-relieving Celebrex and Lyrica, pneumonia vaccine Prevnar, and erectile dysfunction medication Viagra, as well as arthritis medicine Enbrel, antibiotic Zyvox, and blood-thinning Eliquis, are among the company’s top prescription items. Generic medications and consumer health goods are also manufactured and sold by the company.

    In partnership with BioNTech SE, a German biotechnology firm, Pfizer recently produced an mRNA-based vaccine for COVID-19. The vaccine’s efficacy has been verified in several trials to be between 90 and 100 percent.

    Pfizer – Mission and Vision

    The vision statement of Pfizer is – “Innovate to bring therapies to patients that significantly improve their lives.”

    Pfizer mission statement is “to become the world’s most valued company to all of these people.” It zeroes down on the achievements that the company desires while at the same time meeting the expectations of all its patients. It focuses on the company’s desired outcomes while still meeting all of its patients’ needs.


    Panacea Biotec Company Profile – India’s 2nd Largest Vaccine Maker
    Company Profile is an initiative by StartupTalky to publish verified informationon different startups and organizations. The content in this post has beenapproved by Panacea Biotec. Since the pandemic began, India has recorded more than 19 million cases, secondonly to the United States. Over 200…


    Pfizer – Founder and History

    Charles Pfizer and Charles Erhart, cousins who had immigrated to the United States from Ludwigsburg, Germany, founded Pfizer in 1849.

    The company, which was based on Bartlett Street in Williamsburg, New York, developed chemical compounds, including an antiparasitic called santonin. Both in their mid-20s, the two men started a fine chemicals company in a Brooklyn factory with a loan from Pfizer’s father. Pfizer’s chemist skills were combined with Erhart’s confectioner training in the company’s first product, a palatable anti-parasitic drug that tasted like toffee. It was a huge success, and it set the tone for the company’s future growth.

    The American Civil War, which broke out shortly after in 1862, had an equal effect on the emerging pharmaceutical industry as it did on American society as a whole. Drug manufacturers were just as much a part of the “first industrial war” as arms manufacturers. The sudden demand for massive amounts of painkillers and antiseptics for the Union armies, like that of their rival Squibb, presented a huge opportunity to increase production. Pfizer’s sales had doubled since the beginning of the war in 1868, and their product ranges had greatly expanded.

    Following the battle, Pfizer began to concentrate on industrial chemicals rather than drugs, manufacturing citric acid for the burgeoning soft drink industry, which fueled the expansion of brands including Coca-Cola and Dr. Pepper in the 1880s. For several years, this was their mainstay, setting the groundwork for their continued expansion. When the supply of tartaric acid was interrupted by the civil war and higher tariffs, Pfizer expanded its production to become the leading chemical supplier in the United States.

    Pfizer – Covid-19 Vaccine

    In April 2020, Pfizer collaborated with BioNTech to start developing a COVID-19 vaccine in response to the coronavirus pandemic. The BNT162b2 vaccine candidate is an mRNA vaccine. The drug-maker announced in November 2020 that results from Phase 3 clinical trials showed the vaccine was safe and reliable, with a 95 percent efficacy rate. It needs two doses, separated by 21 days.

    Pfizer and BioNTech submitted an emergency use permission request to the FDA a few days after the positive clinical trial results were announced. The FDA approved the Pfizer-BioNTech COVID-19 vaccine for distribution in the United States on December 11, 2020.


    Siemens AG | German Multinational Company | Company Profile |
    Company Profile is an initiative by StartupTalky to publish verified informationon different startups and organizations. The content in this post has beenapproved by Siemens. Siemens Limited is a holding company engaged in the manufacturing of electricmotors, generators, transformers and electri…


    Pfizer – Key Pharmaceutical Products

    Many well-known products are manufactured and marketed by Pfizer. Some of the company’s most well-known brands are mentioned below –

    • Nexium24HR – Over-the-counter heartburn drug
    • Prevnar 13 – Vaccine to prevent pneumonia
    • Advil – Non-steroidal anti-inflammatory drug (pain reliever)
    • Viagra – Erectile dysfunction drug
    • Xanax – Psychoactive medicine
    • Zoloft – SSRI antidepressant
    • Lipitor – Cholesterol medicine
    • Chantix – Smoking cessation drug
    • Bextra – Cox-2 inhibitor (pain reliever)
    • Depo-Testosterone – Testosterone replacement therapy drug
    • EpiPen – Auto-injector emergency allergy medicine
    • Celebrex – Non-steroidal anti-inflammatory drug (pain reliever)
    • Zithromax – Macrolide antibiotic (bacterial infections)
    • Eliquis – Anticoagulant (blood thinner)
    • Protonix – Proton pump inhibitor acid-reducer
    • Prempro – Hormone replacement drug therapy
    • Effexor – SNRI antidepressant

    Pfizer – Name, Logo, and Tagline

    Pfizer’s company name is after the founder Charles Pfizer and its logo is shaped like a tablet of medicine. The oval-shaped logo is a powerful brand identity that conveys a message of optimism, well-being, and progress. As opposed to the initial limit “P,” the letter “f” is intentionally made larger.

    The tagline outlines Pfizer’s purpose, “Breakthroughs that change patients’ lives.”

    Pfizer's Company Logo
    Pfizer’s Company Logo

    Pfizer – Business Model

    Pfizer Innovative Health and Pfizer Essential Health are the company’s two commercial divisions.

    Pfizer Innovative Health is dedicated to the development and commercialization of pharmaceuticals and vaccines. Internal medicine, vaccination, oncology, inflammation and immunology, rare diseases, and consumer healthcare are among IH’s therapeutic fields.

    Legacy labels, branded generics, generic sterile injectable drugs, biosimilars, and infusion systems are all included in the Pfizer Essential Health category. EH also has a research and development department, as well as a contract manufacturing division. Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq, and Viagra are some of the company’s brands.


    HealthKart | Authentic Health Products Online | Overview
    Company Profile is an initiative by StartupTalky to publish verified informationon different startups and organizations. The content in this post has beenapproved by the organization it is based on. Healthcare is going to fundamentally transform in years to come. Technologyadvancements are at …


    Pfizer – Key Financial Metrics

    The table below highlights some of the key financial metrics of Pfizer (extracted from the company’s annual reports)

    Financial Metric 2020 (In Millions) 2019 (In Millions)
    Total Income $9,616 $16,273
    PAT(Margin) -11.89 219.75
    Equity Share Capital 45.75 45.75
    Net Fixed Assets 2513.05 2127.65

    Pfizer – Revenue and Growth

    Pfizer’s COVID-19 vaccine sales exceeded analyst expectations by about 60%. As of mid-April 2021, the company produced 1.6 billion doses of the vaccine under signed contracts. Pfizer’s operating sales increased by 8% even without revenue from the COVID-19 vaccine.

    Year Amount Percentage Change From Last Year
    2021 $14.582B +21.23%
    2020 $41.908B +1.79%
    2019 $41.172B +0.85%
    2018 $40.825B -22.31%


    Serum Institute of India – World’s Largest Vaccine Manufacturer
    Company Profile is an initiative by StartupTalky to publish verified informationon different startups and organizations. The content in this post has beenapproved by Serum Institute of India. India has reported more than 19 million cases since the pandemic started, secondonly to the United State…


    Pfizer – Investments

    Date Organization Name Round Amount
    Mar 30, 2021 Pyxis Oncology Series B $152M
    Feb 17, 2021 Imcyse Series B €21.3M
    Oct 29, 2020 LianBio Venture Round $310M
    Jul 29, 2020 Cerevel Therapeutics Post-IPO Equity $320M
    May 19, 2020 Amplyx Pharmaceuticals Series C $53M
    Apr 22, 2020 FoRx Therapeutics Seed Round €10M
    Mar 20, 2019 Vivet Therapeutics Corporate Round €45M
    Feb 19, 2019 Gliknik Corporate Round $15M
    Nov 13, 2018 NextCure Series B $93M
    Apr 19, 2018 Allogene Therapeutics Series A $411.8M

    Pfizer – Acquisitions

    Acquiree Name About Acquiree Date Amount
    Amplyx Pharmaceuticals Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems Apr 28, 2021
    Array BioPharma Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs. Jun 17, 2019 $11.4B
    Therachon Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases May 8, 2019 $340M
    Medivation Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases Aug 22, 2016 $14B
    Bamboo Therapeutics Bamboo Therapeutics Announces the Acquisition of the Vector Core Manufacturing Facility from UNC-Chapel Hill Aug 1, 2016 $654M
    BIND Therapeutics BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics. Jul 27, 2016 $40M
    Anacor Pharmaceutical Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform. May 16, 2016 $5.2B
    Hospira Hospira is a provider of injectable drugs and infusion technologies. Feb 5, 2015 $15B
    Redvax A privately held Swiss biopharmaceutical company Jan 5, 2015
    Baxter International – Marketed Vaccines The portfolio that was consists of NeisVac-C and FSME-IMMUN/TicoVac. Jul 30, 2014 $635M


    Acquisitions of Indian Startup by its Competitor | StartupTalky
    What do you mean by the term Acquisitions? On what metrics the company acquiresother companies? Is acquiring other competitor companies legal? Which are someof the latest acquired companies? Interesting isn’t it? According to Investopedia, the definition of Acquisitions is as follows- > An acqu…


    Pfizer – Competitors

    The top competitors of Pfizer are Merck, Novartis, BMS, Johnson & Johnson, GSK, Abbott, Cipla, Roche, Eli Lilly, and Bayer.


    List of Companies developing Covid 19 vaccine around the World
    The vaccination drive for Covid 19 has been started across the globe. Vaccineshave been developed and manufactured by a lot of companies around the world.Below are the top companies which are involved in the development andmanufacturing of Covid vaccines. PfizerAstra ZenecaSerum Institute of I…


    Pfizer – Challenges Faced

    • With exclusivity for Pfizer’s second-best-selling medication, Lyrica, expected to expire in June, the pharma expects a $2.6 billion sales hit from competitive pressures, almost $1 billion more than in 2018.
    • As of November 2020, Pfizer’s Covid-19 vaccine, made in partnership with the German firm BioNTech, was  stored at subzero temperatures, and there were lots of distribution challenges in rolling it out in the weeks ahead.

    Pfizer is “running at critical supply limitations,” Dr. Bourla, the CEO said, adding that he hopes the government deploys the Defense Production Act to solve the problem.

    Meanwhile, the FDA contacted Pfizer about a different problem with its vaccine. According to some press accounts, several pharmacists giving the shots found that each vial contained more than the planned five doses. They wondered if they could eke out another dose, or even two, from the leftovers.

    Pfizer – Future Plans

    Pfizer has revealed plans to increase sales in Latin America, Eastern Europe, and Asia, which are all developing markets. The organization will use its global reach and product portfolio to provide health solutions to the rising and underserved population of middle-income patients in these areas.

    The company identified four factors that will aid its expansion in the developing Asian pharmaceutical market, which is worth $47 billion. Expanding its current presence in high-growth markets, establishing leadership in oncology, tailoring portfolio offerings to local consumer needs, and leveraging global manufacturing and R&D in Asia are among these factors.

    Pfizer expects to spend $5 billion in capital projects in the United States over the next five years, including expanding its manufacturing footprint in the country. In 2019, it announced an additional half-billion-dollar investment in Sanford, North Carolina, for the construction of a cutting-edge gene therapy manufacturing facility.

    Pfizer – FAQs

    What does Pfizer do?

    Pfizer is a research-based multinational biopharmaceutical corporation that develops, manufactures, and distributes healthcare products. Medicines and vaccines are part of its global portfolio.

    Who founded Pfizer?

    Charles Pfizer and Charles Erhart, cousins who had immigrated to the United States from Ludwigsburg, Germany, founded Pfizer in 1849.

    Which companies do Pfizer compete with?

    The top competitors of Pfizer are Merck, Novartis, BMS, Johnson & Johnson, GSK, Abbott, Cipla, Roche, Eli Lilly, Bayer.

    Does Pfizer produce Covid-19 vaccine?

    Yes, Pfizer produces Covid-19 vaccine.

    Does Pfizer export Covid-19 vaccine?

    Yes, Pfizer exports Covid-19 vaccine.

  • How Facebook’s Vaccine finder tool will help India Vaccinate

    Facebook Inc on 30 April 2021 had announced that it is planning to roll out a new feature in its digital platform in India. The vaccination drive for the people above the age of 18 has been said to be started from the month of May.

    The second wave of Covid-19 has been increasing significantly in the country with vaccination being given the most important priority at this moment. The new feature is a finder tool that will help India in the process of Covid-19 vaccination. Let’s look at how the new finder tool of Facebook will help India to vaccinate the people.

    About Facebook
    Facebook’s Vaccine Finder Tool
    Additional features of the Tool
    Facebook’s help and support
    FAQ

    About Facebook

    Facebook is an American based social media platform and social networking service. The company was launched in the year 2004. The digital platform is available in around 111 languages and available worldwide except in the countries where it is blocked.

    As of December 2020, the company has around 2.8 billion monthly active users and during the 2010s Facebook was the most downloaded mobile app globally.

    As of April 2021, there were around 406,100,000 users in India. It accounted for 28.9 % of the entire population of the country. The largest user group in the country was people aged in between 25 to 34 years. The majority of the users were men with around 74.5% of the users.


    The Covid-19 Pandemic Proved To Be Lucrative For These Industries
    The sudden outbreak of the Covid-19 pandemic has left no industries and sectorsunscathed, worldwide. And many parts of the economy have taken a hit because ofit. While the pandemic has created global economic uncertainty, it has also provedto be lucrative for some industries and created new mark…


    Facebook’s Vaccine Finder Tool

    On 30 April 2021, Facebook Inc had announced that the company has partnered with the Government of India to introduce a new feature which will be a vaccine finder tool. The finder tool will be available on the mobile application of Facebook in India from this week.

    The vaccine finder tool will be available in 17 different languages in India. The finder tool will help the people locate the nearest vaccine center and the operation time period of the vaccine centers according to the health ministry.

    Additional features of the Tool

    Facebook said in a statement that the new tool will help people in identifying the walk-in options as well for the people above the age of 45. It will also provide a link to register on the CoWin website in order to register and schedule the appointment for the vaccination.

    The tool can be accessed in the Covid-19 information center. The Social media company also communicated that it is supporting the NGOs and UN agencies in India with ad credits. They are also providing insights and trying to help them reach the majority of the country through their digital platform with Covid vaccines and health information to prevent covid-19 infections.


    Why does Bill Gates Believe World will be normal by 2022
    The coronavirus pandemic has affected almost all the countries across the globe.The lockdowns and various other restrictions have hit the major developing anddeveloped countries’ economies and the lifestyle of the people. But Bill Gatesbelieves that everything would get to normal by 2022. Let’s l…


    Facebook’s help and support

    Facebook has also committed with UNICEF India to provide health resources about when to seek emergency care and how to manage covid-19 with mild symptoms at home. The above information is available on the Covid -19 information center and the feed of Facebook’s platform.

    The company said that on Instagram they are promoting this feature in the explore feature in the form of guides.

    Instagram Covid Guide
    Instagram Covid Guide

    In the last week of April 2021, the Chief of Facebook Mark Zuckerberg had announced a USD 10 million grant for covid-19 emergency response efforts in India. To deploy these funds the social media giant is partnering with the organizations such as US-India Strategic Partnership Forum (USISPF) and United Way, Swasth, Hemkunt Foundation.

    The funds will mainly be used to access the critical medical supplies which include ventilators, increasing hospital bed capacity, BiPAP machines and 5000+ oxygen concentrators.

    FAQ

    What is Facebook’s net worth?

    $279.95 billion is the net worth of Facebook as of 2021.

    Who owns Facebook now?

    Mark Zuckerberg is the founder and owner of Facebook.

    What percent of Facebook does Zuckerberg own?

    Mark Zuckerberg owns 29.3 percent of Facebook.

    Conclusion

    The covid-19 second wave has increased the number of cases in the country and this step from Facebook will be a great help for the Indian government and the citizens in the country. The vaccination drive is expected to be done in a smoother way.

  • List of Companies developing Covid 19 vaccine around the World

    The vaccination drive for Covid 19 has been started across the globe. Vaccines have been developed and manufactured by a lot of companies around the world. Below are the top companies which are involved in the development and manufacturing of Covid vaccines.

    Pfizer
    Astra Zeneca
    Serum Institute of India
    Bharath Biotech
    Moderna
    BioNTech
    Novavax
    Sinovac
    CanSino Biologics
    Johnson & Johnson
    Inovio
    R-Pharm
    BIOCAD
    Pharmasyntez
    FAQ

    Pfizer

    Pfizer is an American based pharmaceutical company. It was founded in the year 1984 and has its headquarters in New York. Pfizer is one of the world’s largest pharmaceutical company. The company develops and manufactures vaccines and medicines for a wide range of medical disciplines.

    Pfizer is in the process of development and manufacturing of mRNA vaccine for Covid 19.

    Astra Zeneca

    Astra Zeneca is a British-Swedish multinational biotechnology and pharmaceutical company. The company has its headquarters in Cambridge, England and was founded in the year 1999. Astra Zeneca has a portfolio of products for major diseases in areas such as oncology, cardiovascular, infection, respiratory, etc.

    Astra Zeneca is well known for its involvement in developing the Oxford-Astra Zeneca Covid 19 vaccines.

    Serum Institute of India

    Serum Institute of India is an Indian Pharmaceuticals and Biotechnology company. It is the largest manufacturer of Vaccines around the globe. The company was founded in 1966 by Cyrus Poonawalla and is based in Pune, India. Adar Poonawalla is the Chairman, President, and CEO of the company.

    Serum Institute of India has tied up with Astra Zeneca which is a pharmaceutical company. The company has released a vaccine called Covishield.

    Bharath Biotech

    Bharath Biotech International Limited is an Indian company which deals with biotechnology. The company has its headquarters in Hyderabad, India. The company is involved in drug development, manufacture of vaccines, drug discovery, bio-therapeutics, healthcare products, and pharmaceuticals.

    It has partnered with the state-run Indian Council of Medical research in developing a vaccine against Covid-19 called as COVAXIN.


    How Machine Learning is Revolutionizing the Healthcare Industry
    What if i tell you that in near future surgeries will be performed by Machines.Yes, machine learning has advanced rapidly that in near future it will bepossible to perform medical surgeries with minimum or no interventions by aPhysician. Machine learning is widely used in healthcare industry in …


    Moderna

    Moderna is a an American-based biotechnology and pharmaceutical company. The company has its headquarters in Cambridge. The company focuses on discovery of drugs, development of drugs and vaccine technologies.

    Moderna is in the process of developing mRNA vaccine for Covid 19.

    BioNTech

    BioNTech is the short form for Biopharmaceutical New Technologies. It is a German based biotechnology company which has its headquarters in Mainz Germany. The company was founded in the year 2008.

    BioNTech is also in the process of developing mRNA vaccine for Covid 19.

    Novavax

    Novavax is an American based Pharmaceutical company which is involved in the manufacturing of vaccines. The company was founded in the year 1987 and is located in Gaithersburg United States.

    Novavax is in the process of development and manufacturing NVX-CoV2373 which is a vaccine for Covid 19.

    Sinovac

    Sinovac Biotech Ltd is a Chinese based biotechnology company. The company was founded in the year 1999 which is located in Beijing, China. The company focuses in the research and development, commercialization and manufacturing of vaccines which will protect against human infectious diseases.

    Sinovac Biotech Ltd is in the process of development and manufacturing of CoronaVac which is a vaccine for Covid 19.

    CanSino Biologics

    CanSino Biologics is a Chinese vaccine company. The company was founded in the year 2009 and is headquartered in Tianjin, China. The company is in the process of development and manufacturing of Ad5-nCOV which is a vaccine for Covid 19.

    Rate of COVID-19 vaccination worldwide as of April 10, 2021
    Rate of COVID-19 vaccination worldwide as of April 10, 2021

    How Startups can scale up Covid vaccination drive in India
    Covid has created a large negative impact on most of the industries in thesector. It has disrupted the economic activities in the country. Most of thesectors are being impacted due to the pandemic. Let’s look at how the variousstartups can help the government in the Covid-19 vaccination drive. H…


    Johnson & Johnson

    Johnson & Johnson is an American multinational corporation. The company was founded in the year 1886 and has its headquarters in New Jersey, New York. It focuses on developing medical devices, consumer packaged goods and pharmaceuticals.

    Johnson & Johnson is in the process of developing Ad26.COV2.S which is a type of vaccine for Covid 19.

    Inovio

    Inovio Pharmaceuticals is an American based biotechnology company. It was found in the year 1983 and has its headquarters in Pennsylvania. It focuses on the development, discovery and commercialization of synthetic DNA products. The products are used for treating Cancer and infectious diseases.

    Inovio Pharmaceuticals is in the process of developing INO-4800 which is a DNA based plasmid Covid 19 vaccine.

    R-Pharm

    R-Pharm is an international pharmaceutical company. It has its headquarters in Russia. The company was founded in the year 2001 by Alexey Repik. The company concentrates on areas which include research, development, production and marketing of drugs which is primarily on inpatient and medical care.

    Their main focus is on activities such as production of finished dosage forms, research and development of drugs and technologies, introduction to Russian market of pharmaceuticals, etc.

    In December 2020, the company had got into a memorandum of understanding (MOU) with Astra Zeneca in the manufacturing of Oxford Astra Zeneca Covid-19 Vaccine.


    Market Growth Of Online Doctor Consultation During Lockdown
    In an era, where everything is available at the click of a button it is nosurprise that even a specialist doctor or a clinical examination could be doneonline. Online doctor consultation is a coveted field in India and is able tooffer services like telehealth, telemedicine, telecare, and digital …


    BIOCAD

    BIOCAD is a Russian based pharmaceutical company. The company has its headquarters in Saint Petersburg, Russia. The company has offices in Belarus, India, China, Brazil and even United States.  It is said that 40% of the company’s employees are scientists.

    The company focuses on discovering, developing and manufacturing vertically integrated drugs. The company has around 50 products in its portfolio. BIOCAD is currently developing a mRNA vaccine for Covid-19.

    Pharmasyntez

    Pharmasyntez is a Russian based Pharmaceutical company. The company was founded in the year 1997 in Irkutsk. The first factory of the company was opened in the year 1999.

    The company has more than 50 products in its portfolio. The company also supplies medicines to the largest pharmaceutical distributors in Russia. It is one of the top 3 fastest growing pharmaceutical companies in Russia.

    Pharmasyntez is expected to start the production of Covid-19 vaccine Sputnik V.

    FAQ

    Is India exporting Covid vaccine?

    Indian government has decided not to ban the commercial export of Covid-19 vaccines by the two manufacturers based in India, for now.

    Who issued the official name of COVID-19?

    The official names COVID-19 and SARS-CoV-2 were issued by the WHO on 11 February 2020.

    Is the US using AstraZeneca vaccine?

    AstraZeneca’s Covid-19 vaccine has not yet been rolled out in the U.S. as the Food and Drug Administration (FDA) has only authorized the use of vaccines developed by Pfizer, Moderna and Johnson & Johnson.

    Conclusion

    These are the top companies in the world that is involved in the manufacturing and development of Covid 19 vaccines.

  • How Startups can help in Covid Vaccination in India

    Covid has created a large negative impact on most of the industries in the sector. It has disrupted the economic activities in the country. Most of the sectors are being impacted due to the pandemic. Let’s look at how the various startups can help the government in the Covid-19 vaccination drive.

    How Startups can scale up Covid vaccination drive
    Role of IT in Covid vaccination drive
    Role of Logistics in Covid 19 vaccination drive
    How Government can utilize this data
    FAQ

    How Startups can scale up Covid vaccination drive

    Since the major sectors of the country have been disrupted due to the ongoing pandemic. There is an opportunity for the various startups to help the government in the Covid-19 vaccination drive. It is said that in every crisis there will be an opportunity.

    The healthcare startups have a seminal opportunity in helping the government by aiding and facilitating the vaccination drive in the country. Whereas the other startups like healthcare, IT, logistics, etc. will have plenty of opportunities in various other activities.


    Reasons Why These Startup Sectors Bloomed During Lockdown
    In the unprecedented time, where everyone is talking about the economic slowdownand financial difficulties, there have been a few startups sectors that havemanaged grow exponentially well. The covid 19 has shaken the world and hasbrought many business to a halt, although startups have lost their …


    Role of IT in Covid vaccination drive

    IT systems can play a really important role in the vaccination drive. They can help the government by playing a central role in creating and maintaining information related to the vaccination drive. They can do the enlisting and enumerating the people involved in the drive, they can keep the track of the number of dose intake during the vaccination drive of different people.

    They can also use the various national IDs such as PAN card, Aadhar card, etc. to keep a number and to identify the individuals and their participation in the drive.

    The IT sectors will have to ensure that the vaccination doses are delivered to the vulnerable and the critical sections around the country. They will have to combine their mapping applications and the startups will have to ensure that there is a coordinated vaccination campaign.

    They also play an important role in identifying the genuineness of the vaccinations in the country. They will have to quickly detect it. They will have to identify the counterfeits and prevent the use of such counterfeits in the patients.

    They will have to help the government in finding the source of such counterfeits and also use social media and other online sources to create awareness among the general public regarding the dangers that are caused by these fraudulent vaccines.


    An Overview Of The Online Pharmacy Industry In India
    With the lockdowns restrictions brought over by the Covid Pandemic, mosteconomic activities were paused, millions lost their job and many industriesfaced difficulties. But there were also some industries like Online gaming,Online grocery, Fintech, Telemedicine, Ed tech, online media that were boo…


    Role of Logistics in Covid 19 vaccination drive

    The logistics startups also play a very important role in the vaccination drive. They play a central role in fine tuning the appropriate delivery of the vaccines across the country. The logistics space in India has undergone a lot of developments.

    The logistics in India have been innovating and adapting to the new technology to address the challenges faced due to the transportation. The new innovations and technology adaption in the logistic space can help the government in delivering the Covid vaccines to every nook and corner of the country in regular intervals.

    Logistics market
    Logistics market

    The startups can also conduct various activities to share the social information regarding the Covid vaccine drive. They can help in creating trusted communities and categories people of the similar demographics, same geography or people with the same affinities.

    These details can be used to discuss various factors which include the vaccination experience, after effects, opinions on the facilities and the actual process, best practices in the vaccination process and documentation on how to deal with the various aftermaths can be documented.

    These can be used to share an opinion and be used to socialize for a larger ecosystem.

    How Government can utilize this data

    All the above details can be used by the government for a timely, granular and actionable plan to utilize it for the entire vaccination drive in an idealized fashion. The government can analyze various other factors such as which vaccinations to order, in administering the vaccines such as the ones that are imported and homegrown, where the vaccines are to be shipped and the logistical details of it.

    They can also make decisions on whether to continue the vaccination drive or they will have to continue with a private partnership or public partnership. The government can also analyze the data sets and create vaccination drives in the most needed places and areas.

    They can also redirect the resources such as financial and personnel according to the needs of the vulnerable section in the country.


    Improving Workplace Safety in 2021
    Workplace safety has been and continues to be a hot topic of conversation thisyear. Certainly, there are some extra measures which are appropriate in light ofthe new threat of Covid-19. However, workplace safety is never something to beoverlooked or ignored because it’s important to provide it fo…


    FAQ

    What is the COVID-19 vaccination drive in India?

    COVID-19 vaccination drive has been initiated to cover healthcare and frontline workers and is to be scaled up to cover citizens above 60 years of age and and/or citizen above 45 years of age suffering from comorbidities.

    How many people are vaccinated for Covid in India?

    As of April, 8, India had administered 9,01,98,673 total doses of the Covid-19 vaccine.

    Is there a shortage of vaccines in India?

    Union health minister Harsh Vardhan had stated on that there is no shortage of shots in India. “All the claims of states are baseless and centre is supplying vaccines to all states equitably irrespective of the ruling party.

    Conclusion

    The startups can help the government in making the vaccination drives easier and carrying it forward more effectively. These are the various ways through which the Indian startups can help the government in Covid 19 Vaccination across the country.

  • List of Biotech Companies that are Developing Covid vaccine

    India started its vaccination programme for Covid-19 on 16 January 2021. The vaccination was first prioritized for frontline and healthcare workers. The Covishield vaccine and Covaxin have been approved by the government. There are many more companies working behind developing the vaccine in the country.

    Serum Institute of India
    Bharath Biotech
    Biological E Ltd
    Cadila Healthcare Limited
    Dr.Reddy’s Laboratories Ltd
    FAQ

    Serum Institute of India

    Serum Institute of India is an Indian Pharmaceuticals and Biotechnology company. It is the largest manufacturer of Vaccines around the globe. The company was founded in 1966 by Cyrus Poonawalla and is based in Pune, India. Adar Poonawalla is the Chairman, President, and CEO of the company.

    Serum Institute of India has tied up with Astra Zeneca which is a pharmaceutical company. The company has released a vaccine called Covishield. They have also tied up with a U.S based rival Novavax.Inc.

    The company has received funding from big organizations such as the Bill & Melinda Gates Foundation and Gavi Vaccine group. The funding is for delivering up to 200 million doses of both the vaccines for other low- and middle-income countries across the world and India.

    In June 2020 Astra Zeneca had licensed the company to supply doses of its vaccines of up to 1 billion in numbers. It was concentrated on 60 low- and middle-income countries. Serum Institute of India is working on developing in-house vaccines and has partnered with Austria’s Themis and U.S. biotech firm Codagenix to potentially manufacture their COVID-19 vaccines.

    Serum Institute of India has already made and stored more than 50 million doses of Covishield. The company aims to increase its production to 400 million doses by the by the mid of 2021.

    Bharath Biotech

    Bharath Biotech International Limited is an Indian company which deals with biotechnology. The company has its headquarters in Hyderabad, India. The company is involved in drug development, manufacture of vaccines, drug discovery, bio-therapeutics, healthcare products, and pharmaceuticals.

    The company was founded in the year 1966 by Krishna Ella. Krishna M Ella is the Chairman and the MD of the company. The company is working together with a U.S based company FluGen and the University of Wisconsin-Madison in the development of a vaccine against Covid-19.

    It has partnered with the state-run Indian Council of Medical research in developing a vaccine against Covid-19 called as COVAXIN. The Company is trying to reach an agreement with more than 10 countries in Southern America, Eastern Europe, and Asia to sell their vaccines. The vaccine has been provided to the citizens of India.


    How Entrepreneurs are Helping to Fight COVID-19?
    Needless to mention, Coronavirus has affected every aspect of human life.Lockdowns and social distancing particularly has had immediate effect on severalbanking activities. Thus, at the same time, many efforts are being made to raisefunds and help startups and SMEs. Experts in the sector have gre…


    Biological E Ltd

    Biological E Limited is an Indian company which deals with Biopharmaceuticals. The company has its headquarters in Hyderabad, India. The company is involved in low-cost vaccine production in the country.

    The company was founded in the year 1953 by Datla Venkata Krishnam Raju. Mahima Datla is the Managing Director of the company. The company had started its trials in November. It started its Phase I and Phase II trials.

    The company had come into a partnership with Dynavax technologies and Baylor College of Medicine in Houston for the development of Covid-19 Vaccines.

    Countries Where Coronavirus Vaccine will be produced
    Countries Where Coronavirus Vaccine will be produced

    Cadila Healthcare Limited

    Cadila Healthcare Ltd is an Indian Multinational Company which deals with pharmaceuticals. The company has its headquarters in Ahmedabad, Gujarat, India. The company is involved in the manufacturing of generic drugs. In the fortune India 500 list, the company was ranked 100th in 2020.

    Cadila Healthcare Ltd was founded in the year 1952 by Ramanbhai Patel. Pankaj R Patel is the chairman of the company and the Managing Director of the company is Sharvil P Patel.

    The company got permission to conduct human trials for its Covid-19 vaccine named ZyCOV-D in July 2020 by the Drugs Controller General of India, Government of India. Cadila Healthcare Ltd has said that it will be able to produce up to 100 million doses of vaccines in a year in the initial stages.


    What will be the Scenario after Coronavirus Outbreak?
    Humankind is now facing a global crisis due to Coronavirus outbreak. Perhaps thebiggest crisis of our generation. If the growing novel coronavirus outbreak[https://www.startuptalky.com/tag/coronavirus-outbreak/] becomes a long lastingpandemic, it could result into fundamental changes in the econo…


    Dr.Reddy’s Laboratories Ltd

    Dr. Reddy’s Laboratories is an Indian Multinational Company which deals with the manufacturing and marketing of pharmaceuticals in India and across the globe. The company has its headquarters in Hyderabad, India.

    The company has over 60 active pharmaceutical ingredients (APIs) for drug manufacture, 190 medications, critical care, biotechnology products, and diagnostic kits. The company was founded in the year 1984 by Kallam Anji Reddy, who is the Chairman of the company and Erez Israeli is the CEO of the company.

    The company entered into an agreement with Russia to conduct final trials of its vaccine Gam-COVID-Vac (Sputnik V) Vaccine in India. The company plans to distribute around 100 million doses in the Country.

    The Russian Direct Investment Fund will be supplying the vaccines for distribution in India. The subsidiary company of Dr. Reddy’s Laboratories Ltd Hetero Biopharma has announced that they would produce 100 million doses of Sputnik V.

    FAQ

    Which Covid vaccine is used in India?

    Covishield vaccine, manufactured by Serum Institute of India, and Bharat Biotech’s Covaxin are being used for the vaccination programme.

    How many doses is AstraZeneca vaccine?

    The AstraZeneca COVID-19 vaccine is given on a two-dose schedule.

    What is the official name of the coronavirus disease?

    On 11 February 2020ICTV announced “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” as the name of the new virus.

    Conclusion

    The top companies are in the run for producing the Covid-19 Vaccines in India. There are already some vaccines being provided for the people in the country. 0.43% of the Indian population has already been vaccinated in the Country. Around 32.9 million doses of the vaccines have been provided in the country and 5.87 million have been fully vaccinated.